| Primary |
| Hypertension |
31.6% |
| Pain |
31.6% |
| Osteoporosis |
21.1% |
| Ankylosing Spondylitis |
10.5% |
| Ovarian Cancer |
5.3% |
|
| Renal Failure |
25.0% |
| Bone Development Abnormal |
12.5% |
| Contraindication To Medical Treatment |
12.5% |
| Drug Hypersensitivity |
12.5% |
| Nasal Ulcer |
12.5% |
| Surgery |
12.5% |
| Temporal Arteritis |
12.5% |
|
| Secondary |
| Hypercalcaemia Of Malignancy |
63.6% |
| Osteoporosis |
13.6% |
| Prophylaxis |
9.1% |
| Depression |
4.5% |
| Hormone Replacement Therapy |
4.5% |
| Urinary Incontinence |
4.5% |
|
| Haemorrhage Intracranial |
20.0% |
| Hypercalcaemia |
20.0% |
| No Therapeutic Response |
20.0% |
| Deafness Unilateral |
10.0% |
| Pruritus |
10.0% |
| Rash Maculo-papular |
10.0% |
| Tinnitus |
10.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
45.8% |
| Osteoporosis |
9.9% |
| Rheumatoid Arthritis |
7.9% |
| Osteoporosis Postmenopausal |
4.9% |
| Hypertension |
4.7% |
| Product Used For Unknown Indication |
4.2% |
| Back Pain |
3.4% |
| Pain |
2.9% |
| Depression |
2.7% |
| Osteitis Deformans |
2.2% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Arterial Disorder |
1.4% |
| Heart Transplant |
1.4% |
| Metastases To Bone |
1.3% |
| Multiple Myeloma |
1.1% |
| Myocardial Ischaemia |
1.1% |
| Chronic Obstructive Pulmonary Disease |
0.9% |
| Renal Transplant |
0.9% |
| Abnormal Behaviour |
0.7% |
| Agitation |
0.7% |
|
| Vomiting |
13.9% |
| Spinal Fracture |
8.3% |
| Weight Decreased |
8.3% |
| Respiratory Failure |
6.9% |
| Cataract |
5.6% |
| Rash |
5.6% |
| Restless Legs Syndrome |
5.6% |
| Subdural Haematoma |
5.6% |
| Renal Failure |
4.2% |
| Rib Fracture |
4.2% |
| Tremor |
4.2% |
| Wound Drainage |
4.2% |
| Wound Infection Staphylococcal |
4.2% |
| Blood Iron Decreased |
2.8% |
| Candidiasis |
2.8% |
| Hepatic Enzyme Increased |
2.8% |
| International Normalised Ratio Increased |
2.8% |
| Lethargy |
2.8% |
| Myalgia |
2.8% |
| Myocardial Infarction |
2.8% |
|
